Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 631 entries
Sorted by: Best Match Show Resources per page
A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study.

Iranian journal of pharmaceutical research : IJPR

Majd M, Hashemian F, Hosseini SM, Vahdat Shariatpanahi M, Sharifi A.
PMID: 26330878
Iran J Pharm Res. 2015;14(3):891-9.

This study was designed to examine the antidepressant effect of celecoxib (200 mg/day) augmentation of sertraline in the treatment of female patients with first episode of major depression over 8 weeks of therapy. Thirty female outpatients diagnosed with first...

Cite
Majd M, Hashemian F, Hosseini SM, et al. A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study. Iran J Pharm Res. 2015;14(3):891-9
Majd, M., Hashemian, F., Hosseini, S. M., Vahdat Shariatpanahi, M., & Sharifi, A. (2015). A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study. Iranian journal of pharmaceutical research : IJPR, 14(3), 891-9.
Majd, Marzieh, et al. "A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study." Iranian journal of pharmaceutical research : IJPR vol. 14,3 (2015): 891-9.
Majd M, Hashemian F, Hosseini SM, Vahdat Shariatpanahi M, Sharifi A. A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study. Iran J Pharm Res. 2015;14(3):891-9. PMID: 26330878; PMCID: PMC4518118.
Copy Download .nbib Format: NLM
Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort.

The primary care companion for CNS disorders

Jablonski KL, Devore MD, Ryan MA, Streeter EL, Tolentino JC, Klinski AA, Bahlawan N.
PMID: 27057415
Prim Care Companion CNS Disord. 2015 Dec 03;17(6). doi: 10.4088/PCC.15m01843. eCollection 2015.

OBJECTIVE: To describe outpatient prescription treatment for active-duty military members with posttraumatic stress disorder (PTSD). Medical records were screened for drug-drug interactions with PTSD-related medications and for adverse drug events.METHOD: A retrospective chart review was conducted of the medical...

Cite
Jablonski KL, Devore MD, Ryan MA, et al. Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. Prim Care Companion CNS Disord. 2015;17(6)doi: 10.4088/PCC.15m01843.
Jablonski, K. L., Devore, M. D., Ryan, M. A., Streeter, E. L., Tolentino, J. C., Klinski, A. A., & Bahlawan, N. (2015). Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. The primary care companion for CNS disorders, 17(6), . https://doi.org/10.4088/PCC.15m01843
Jablonski, Kara L, et al. "Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort." The primary care companion for CNS disorders vol. 17,6 (2015). doi: https://doi.org/10.4088/PCC.15m01843
Jablonski KL, Devore MD, Ryan MA, Streeter EL, Tolentino JC, Klinski AA, Bahlawan N. Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. Prim Care Companion CNS Disord. 2015 Dec 03;17(6). doi: 10.4088/PCC.15m01843. eCollection 2015. PMID: 27057415; PMCID: PMC4805416.
Copy Download .nbib Format: NLM
Development of Tinnitus at a Low Dose of Sertraline: Clinical Course and Proposed Mechanisms.

Case reports in psychiatry

Miller CW.
PMID: 27703829
Case Rep Psychiatry. 2016;2016:1790692. doi: 10.1155/2016/1790692. Epub 2016 Sep 15.

No abstract available.

Cite
Miller CW. Development of Tinnitus at a Low Dose of Sertraline: Clinical Course and Proposed Mechanisms. Case Rep Psychiatry. 2016;2016:1790692doi: 10.1155/2016/1790692.
Miller, C. W. (2016). Development of Tinnitus at a Low Dose of Sertraline: Clinical Course and Proposed Mechanisms. Case reports in psychiatry, 20161790692. https://doi.org/10.1155/2016/1790692
Miller, Christopher W T. "Development of Tinnitus at a Low Dose of Sertraline: Clinical Course and Proposed Mechanisms." Case reports in psychiatry vol. 2016 (2016): 1790692. doi: https://doi.org/10.1155/2016/1790692
Miller CW. Development of Tinnitus at a Low Dose of Sertraline: Clinical Course and Proposed Mechanisms. Case Rep Psychiatry. 2016;2016:1790692. doi: 10.1155/2016/1790692. Epub 2016 Sep 15. PMID: 27703829; PMCID: PMC5040800.
Copy Download .nbib Format: NLM
Electrochemical Synthesis and Kinetic Evaluation of Electrooxidation of Acetaminophen in the Presence of Antidepressant Drugs.

Iranian journal of pharmaceutical research : IJPR

Nematollahi D, Feyzi Barnaji B, Amani A.
PMID: 26664378
Iran J Pharm Res. 2015;14(4):1115-22.

With the aim of obtaining information about drug-drug interaction (DDI) between acetaminophen and some of antidepressant drugs (fluoxetine, sertraline and nortriptyline), in the present work we studied the electrochemical oxidation of acetaminophen (paracetamol) in the presence of these drugs...

Cite
Nematollahi D, Feyzi Barnaji B, Amani A. Electrochemical Synthesis and Kinetic Evaluation of Electrooxidation of Acetaminophen in the Presence of Antidepressant Drugs. Iran J Pharm Res. 2015;14(4):1115-22
Nematollahi, D., Feyzi Barnaji, B., & Amani, A. (2015). Electrochemical Synthesis and Kinetic Evaluation of Electrooxidation of Acetaminophen in the Presence of Antidepressant Drugs. Iranian journal of pharmaceutical research : IJPR, 14(4), 1115-22.
Nematollahi, Davood, et al. "Electrochemical Synthesis and Kinetic Evaluation of Electrooxidation of Acetaminophen in the Presence of Antidepressant Drugs." Iranian journal of pharmaceutical research : IJPR vol. 14,4 (2015): 1115-22.
Nematollahi D, Feyzi Barnaji B, Amani A. Electrochemical Synthesis and Kinetic Evaluation of Electrooxidation of Acetaminophen in the Presence of Antidepressant Drugs. Iran J Pharm Res. 2015;14(4):1115-22. PMID: 26664378; PMCID: PMC4673939.
Copy Download .nbib Format: NLM
Aripiprazole for Treatment of Apathy.

Innovations in clinical neuroscience

Monga V, Padala PR.
PMID: 26634180
Innov Clin Neurosci. 2015 Sep-Oct;12(9):33-6.

OBJECTIVE: The objective of this article is to present a case of improved outcome of apathy syndrome with aripiprazole.CASE SUMMARY: A 42-year-old man with depression and seizure disorder had significant apathy that did not respond to carbamazepine, sertraline, and...

Cite
Monga V, Padala PR. Aripiprazole for Treatment of Apathy. Innov Clin Neurosci. 2015;12(9):33-6
Monga, V., & Padala, P. R. (2015). Aripiprazole for Treatment of Apathy. Innovations in clinical neuroscience, 12(9), 33-6.
Monga, Varun, and Padala, Prasad R. "Aripiprazole for Treatment of Apathy." Innovations in clinical neuroscience vol. 12,9 (2015): 33-6.
Monga V, Padala PR. Aripiprazole for Treatment of Apathy. Innov Clin Neurosci. 2015 Sep-Oct;12(9):33-6. PMID: 26634180; PMCID: PMC4655898.
Copy Download .nbib Format: NLM
Identification of a male with fragile X syndrome through newborn screening.

Intractable & rare diseases research

Famula J, Basuta K, Gane LW, Hagerman RJ, Tassone F.
PMID: 26668780
Intractable Rare Dis Res. 2015 Nov;4(4):198-202. doi: 10.5582/irdr.2015.01031.

A pilot newborn screening (NBS) study for fragile X syndrome was recently conducted at the University of California, Davis Medical Center. The screening study identified a case of a male with the full mutation completely methylated and no detectable...

Cite
Famula J, Basuta K, Gane LW, et al. Identification of a male with fragile X syndrome through newborn screening. Intractable Rare Dis Res. 2015;4(4):198-202doi: 10.5582/irdr.2015.01031.
Famula, J., Basuta, K., Gane, L. W., Hagerman, R. J., & Tassone, F. (2015). Identification of a male with fragile X syndrome through newborn screening. Intractable & rare diseases research, 4(4), 198-202. https://doi.org/10.5582/irdr.2015.01031
Famula, Jessica, et al. "Identification of a male with fragile X syndrome through newborn screening." Intractable & rare diseases research vol. 4,4 (2015): 198-202. doi: https://doi.org/10.5582/irdr.2015.01031
Famula J, Basuta K, Gane LW, Hagerman RJ, Tassone F. Identification of a male with fragile X syndrome through newborn screening. Intractable Rare Dis Res. 2015 Nov;4(4):198-202. doi: 10.5582/irdr.2015.01031. PMID: 26668780; PMCID: PMC4660861.
Copy Download .nbib Format: NLM
Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies.

Psychiatry investigation

Yoon H, Oh DJ, Suh HS, Lee KU, Lim SW, Lee JY, Yang JC, Lee JH, Ha J, Lee BH, Kang SG, Yoon HK, Moon J, Bae SM, Kwon Y, Kim HC, Oh KS.
PMID: 29475215
Psychiatry Investig. 2018 Feb;15(2):147-155. doi: 10.30773/pi.2017.05.01. Epub 2017 Nov 29.

OBJECTIVE: The aim of the present study was to provide clinical consensus and evidence regarding initial treatment strategies for the pharmacological treatment of social anxiety disorder (SAD) in Korea.METHODS: We prepared a questionnaire to derive a consensus from clinicians...

Cite
Yoon H, Oh DJ, Suh HS, et al. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry Investig. 2017;15(2):147-155doi: 10.30773/pi.2017.05.01.
Yoon, H., Oh, D. J., Suh, H. S., Lee, K. U., Lim, S. W., Lee, J. Y., Yang, J. C., Lee, J. H., Ha, J., Lee, B. H., Kang, S. G., Yoon, H. K., Moon, J., Bae, S. M., Kwon, Y., Kim, H. C., & Oh, K. S. (2018). Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry investigation, 15(2), 147-155. https://doi.org/10.30773/pi.2017.05.01
Yoon, Hyungkun, et al. "Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies." Psychiatry investigation vol. 15,2 (2018): 147-155. doi: https://doi.org/10.30773/pi.2017.05.01
Yoon H, Oh DJ, Suh HS, Lee KU, Lim SW, Lee JY, Yang JC, Lee JH, Ha J, Lee BH, Kang SG, Yoon HK, Moon J, Bae SM, Kwon Y, Kim HC, Oh KS. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry Investig. 2018 Feb;15(2):147-155. doi: 10.30773/pi.2017.05.01. Epub 2017 Nov 29. PMID: 29475215; PMCID: PMC5900408.
Copy Download .nbib Format: NLM
Obsessive-Compulsive Disorder with Suicide Obsessions in a First Responder without Previous Diagnosis of OCD or History of Suicide Attempts.

Case reports in psychiatry

Rachamallu V, Song MM, Liu H, Giles CL, McMahon T.
PMID: 29098105
Case Rep Psychiatry. 2017;2017:4808275. doi: 10.1155/2017/4808275. Epub 2017 Oct 02.

Obsessive-compulsive disorder (OCD) is a distressing and often debilitating disorder characterized by obsessions, compulsions, or both that are time-consuming and cause impairment in social, occupational, or other areas of functioning. There are many published studies reporting higher risk of...

Cite
Rachamallu V, Song MM, Liu H, et al. Obsessive-Compulsive Disorder with Suicide Obsessions in a First Responder without Previous Diagnosis of OCD or History of Suicide Attempts. Case Rep Psychiatry. 2017;2017:4808275doi: 10.1155/2017/4808275.
Rachamallu, V., Song, M. M., Liu, H., Giles, C. L., & McMahon, T. (2017). Obsessive-Compulsive Disorder with Suicide Obsessions in a First Responder without Previous Diagnosis of OCD or History of Suicide Attempts. Case reports in psychiatry, 20174808275. https://doi.org/10.1155/2017/4808275
Rachamallu, Vivekananda, et al. "Obsessive-Compulsive Disorder with Suicide Obsessions in a First Responder without Previous Diagnosis of OCD or History of Suicide Attempts." Case reports in psychiatry vol. 2017 (2017): 4808275. doi: https://doi.org/10.1155/2017/4808275
Rachamallu V, Song MM, Liu H, Giles CL, McMahon T. Obsessive-Compulsive Disorder with Suicide Obsessions in a First Responder without Previous Diagnosis of OCD or History of Suicide Attempts. Case Rep Psychiatry. 2017;2017:4808275. doi: 10.1155/2017/4808275. Epub 2017 Oct 02. PMID: 29098105; PMCID: PMC5643032.
Copy Download .nbib Format: NLM
Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

Journal of personalized medicine

Aka I, Bernal CJ, Carroll R, Maxwell-Horn A, Oshikoya KA, Van Driest SL.
PMID: 29099060
J Pers Med. 2017 Nov 02;7(4). doi: 10.3390/jpm7040014.

Cytochrome P450 (CYP) enzymes are commonly involved in drug metabolism, and genetic variation in the genes encoding CYPs are associated with variable drug response. While genotype-guided therapy has been clinically implemented in adults, these associations are less well established...

Cite
Aka I, Bernal CJ, Carroll R, et al. Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children. J Pers Med. 2017;7(4)doi: 10.3390/jpm7040014.
Aka, I., Bernal, C. J., Carroll, R., Maxwell-Horn, A., Oshikoya, K. A., & Van Driest, S. L. (2017). Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children. Journal of personalized medicine, 7(4), . https://doi.org/10.3390/jpm7040014
Aka, Ida, et al. "Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children." Journal of personalized medicine vol. 7,4 (2017). doi: https://doi.org/10.3390/jpm7040014
Aka I, Bernal CJ, Carroll R, Maxwell-Horn A, Oshikoya KA, Van Driest SL. Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children. J Pers Med. 2017 Nov 02;7(4). doi: 10.3390/jpm7040014. PMID: 29099060; PMCID: PMC5748626.
Copy Download .nbib Format: NLM
Long-Term Sertraline Intake Reverses the Behavioral Changes Induced by Prenatal Stress in Rats in a Sex-Dependent Way.

Frontiers in behavioral neuroscience

Pereira-Figueiredo I, Castellano O, Riolobos AS, Ferreira-Dias G, López DE, Sancho C.
PMID: 28611606
Front Behav Neurosci. 2017 May 29;11:99. doi: 10.3389/fnbeh.2017.00099. eCollection 2017.

Early life stress is a major factor underlying the vulnerability to respond to stressful events later in life. The present study attempted to evaluate the role of prenatal stress affecting the development of stress-related disorders and their reversion by...

Cite
Pereira-Figueiredo I, Castellano O, Riolobos AS, et al. Long-Term Sertraline Intake Reverses the Behavioral Changes Induced by Prenatal Stress in Rats in a Sex-Dependent Way. Front Behav Neurosci. 2017;11:99doi: 10.3389/fnbeh.2017.00099.
Pereira-Figueiredo, I., Castellano, O., Riolobos, A. S., Ferreira-Dias, G., López, D. E., & Sancho, C. (2017). Long-Term Sertraline Intake Reverses the Behavioral Changes Induced by Prenatal Stress in Rats in a Sex-Dependent Way. Frontiers in behavioral neuroscience, 1199. https://doi.org/10.3389/fnbeh.2017.00099
Pereira-Figueiredo, Inês, et al. "Long-Term Sertraline Intake Reverses the Behavioral Changes Induced by Prenatal Stress in Rats in a Sex-Dependent Way." Frontiers in behavioral neuroscience vol. 11 (2017): 99. doi: https://doi.org/10.3389/fnbeh.2017.00099
Pereira-Figueiredo I, Castellano O, Riolobos AS, Ferreira-Dias G, López DE, Sancho C. Long-Term Sertraline Intake Reverses the Behavioral Changes Induced by Prenatal Stress in Rats in a Sex-Dependent Way. Front Behav Neurosci. 2017 May 29;11:99. doi: 10.3389/fnbeh.2017.00099. eCollection 2017. PMID: 28611606; PMCID: PMC5446993.
Copy Download .nbib Format: NLM
Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Ram D, Patil S, Gowdappa B, Rajalakshmi I.
PMID: 26598594
Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-3. doi: 10.9758/cpn.2015.13.3.321.

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam...

Cite
Ram D, Patil S, Gowdappa B, et al. Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clin Psychopharmacol Neurosci. 2015;13(3):321-3doi: 10.9758/cpn.2015.13.3.321.
Ram, D., Patil, S., Gowdappa, B., & Rajalakshmi, I. (2015). Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 13(3), 321-3. https://doi.org/10.9758/cpn.2015.13.3.321
Ram, Dushad, et al. "Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 13,3 (2015): 321-3. doi: https://doi.org/10.9758/cpn.2015.13.3.321
Ram D, Patil S, Gowdappa B, Rajalakshmi I. Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-3. doi: 10.9758/cpn.2015.13.3.321. PMID: 26598594; PMCID: PMC4662177.
Copy Download .nbib Format: NLM
The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods.

Child and adolescent psychiatry and mental health

Thomsen PH, Torp NC, Dahl K, Christensen K, Englyst I, Melin KH, Nissen JB, Hybel KA, Valderhaug R, Weidle B, Skarphedinsson G, von Bahr PL, Ivarsson T.
PMID: 24354717
Child Adolesc Psychiatry Ment Health. 2013 Dec 19;7(1):41. doi: 10.1186/1753-2000-7-41.

BACKGROUND: This paper describes and discusses the methodology of the Nordic long-term OCD-treatment study (NordLOTS). The purpose of this effectiveness study was to study treatment outcome of CBT, to identify CBT non- or partial responders and to investigate whether...

Cite
Thomsen PH, Torp NC, Dahl K, et al. The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods. Child Adolesc Psychiatry Ment Health. 2013;7(1):41doi: 10.1186/1753-2000-7-41.
Thomsen, P. H., Torp, N. C., Dahl, K., Christensen, K., Englyst, I., Melin, K. H., Nissen, J. B., Hybel, K. A., Valderhaug, R., Weidle, B., Skarphedinsson, G., von Bahr, P. L., & Ivarsson, T. (2013). The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods. Child and adolescent psychiatry and mental health, 7(1), 41. https://doi.org/10.1186/1753-2000-7-41
Thomsen, Per Hove, et al. "The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods." Child and adolescent psychiatry and mental health vol. 7,1 (2013): 41. doi: https://doi.org/10.1186/1753-2000-7-41
Thomsen PH, Torp NC, Dahl K, Christensen K, Englyst I, Melin KH, Nissen JB, Hybel KA, Valderhaug R, Weidle B, Skarphedinsson G, von Bahr PL, Ivarsson T. The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods. Child Adolesc Psychiatry Ment Health. 2013 Dec 19;7(1):41. doi: 10.1186/1753-2000-7-41. PMID: 24354717; PMCID: PMC3878347.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 631 entries